Pituitary & hypothalamus

Elevated risk of recurrence and retreatment for silent pituitary adenomas

PituitaryPublished Retrospective cohort study

Main finding · RecurrenceResult — go to the resultHazard ratio 3.2 95% CI 1.6–7.2

Authors' conclusion

Patients undergoing resection of SPAs should be closely monitored for disease recurrence through more frequent clinical follow-up and diagnostic imaging than other adenomas, particularly among patients with STR and younger patients. Several patients can be observed after radiographic recurrence, and the decision to retreat should be individualized. Longitudinal clinical follow-up of SPAs, including an assessment of symptoms, endocrine function, and imaging remains critical.

Study context

Population
All patients undergoing resection of SPAs or functional pituitary adenoma (FPAs) by a single high-volume neurosurgeon, 2007–2018, Brigham and Women's Hospital
Participants
88 vs 200
Exposure
Silent pituitary adenomas (SPAs) vs functional pituitary adenomas (FPAs) after resection
  • SPAn = 88
  • FPAn = 200reference
Outcome
Recurrence
Methodological detailssingle-surgeon, single-centre
  • Single-surgeon
  • Single-centre

Main finding

As reported in the abstract

Hazard ratio

3.2

95% CI 1.6–7.2

SPAvs FPA
HR 3.2 (95% CI 1.6–7.2)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Retreatment for recurrenceHigher likelihood with SPA2.5 (1.0–6.1)

Tumour diameter

P < 0.001

Gross total resection (GTR)

P < 0.001

Recurrence and retreatment by extent of resection (subset analyses)

Recurrence and retreatment more likely for subtotally resected SPAs than subtotally resected FPAs; not observed after gross total resection (GTR)

Predictors of recurrence among SPAs (multivariable analysis)

STR, OR
9.3 (95% CI 1.4-64.0)
Younger age, OR per year
0.92 (95% CI 0.88-0.98)

Management of recurred SPAs

Retreated (repeat surgery n = 11, radiosurgery n = 1)
12 of 19 (63.2%)
Observed
7

Recurrence across SPA subtypes

Similar rates of recurrence across SPA subtypes

Original publication

Elevated risk of recurrence and retreatment for silent pituitary adenomas. Pituitary. Published 12 February 2024. doi:10.1007/s11102-024-01382-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.